Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-04 Sale |
2022-04-05 4:08 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
3,504 | $56.96 | $199,589 | 102,233 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-04 5:03 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
11,496 | $55.05 | $632,855 | 105,737 (Direct) |
View |
| 2022-03-15 Sale |
2022-03-17 8:59 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $39.57 | $49,463 | 796,273 (Indirect Direct) |
View |
| 2022-03-15 Sale |
2022-03-17 6:19 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $39.57 | $14,839 | 167,159 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 6:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $43.53 | $16,324 | 109,811 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-16 4:29 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $45.43 | $17,036 | 106,086 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-16 4:29 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $45.43 | $56,788 | 801,753 (Indirect Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 6:20 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
1,666 | $46.8 | $77,969 | 51,513 (Direct) |
View |
| 2022-02-10 Sale |
2022-02-14 4:15 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $50 | $500,000 | 118,179 (Direct) |
View |
| 2022-02-08 Sale |
2022-02-10 08:32 am |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $45 | $450,000 | 128,857 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-02 4:50 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
375 | $40.58 | $15,218 | 103,566 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-01 5:58 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
1,233 | $38.47 | $47,434 | 53,857 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-04 Exercise |
2022-04-05 4:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
3,504 | $13.85 | 102,233 (Direct) |
View |
| 2022-04-04 Exercise |
2022-04-05 4:08 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
3,504 | $0 | 102,233 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
11,496 | $13.85 | 105,737 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:03 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
11,496 | $0 | 105,737 (Direct) |
View |
| 2022-03-25 Tax Withholding |
2022-03-29 4:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
82 | $49.28 | 28,325 (Direct) |
View |
| 2022-03-15 Exercise |
2022-03-17 8:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 796,273 (Direct) |
View |
| 2022-03-15 Exercise |
2022-03-17 8:59 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 796,273 (Direct) |
View |
| 2022-03-15 Exercise |
2022-03-17 6:19 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
7,000 | $0 | 167,159 (Direct) |
View |
| 2022-03-15 Exercise |
2022-03-17 6:19 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
7,000 | $4.31 | 167,159 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-24 4:33 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
4,100 | $0 | 167,909 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-24 4:33 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
4,100 | $4.31 | 167,909 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-16 4:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 801,753 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-16 4:29 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 801,753 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-15 4:59 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
3,600 | $0 | 168,284 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-15 4:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
3,600 | $4.31 | 168,284 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-15 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
720 | $26.73 | 186,010 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-15 4:58 pm |
N/A 2028-04-12 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
720 | $0 | 186,010 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 6:36 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
491 | $47.12 | 142,444 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 6:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
2,523 | $47.12 | 1,490,351 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
1,057 | $47.12 | 893,650 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:34 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
895 | $47.12 | 44,013 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
705 | $47.12 | 102,861 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:17 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
875 | $47.12 | 103,403 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
175 | $47.12 | 28,407 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $13.85 | 118,179 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 4:15 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $0 | 118,179 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
678 | $47.12 | 118,179 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:13 pm |
N/A 2032-02-09 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
11,853 | $0 | 35,433 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
271 | $47.12 | 35,433 (Direct) |
View |
| 2021-12-08 Ownership |
2022-02-10 4:51 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
3,333 | $0 | 10,000 (Direct) |
View |
Ownership |
2022-02-10 4:51 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
0 | $0 | 10,000 (Indirect) |
View |
| 2021-07-22 Ownership |
2022-02-10 4:49 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
160,000 | $0 | 671,494 (Direct) |
View |
Ownership |
2022-02-10 4:49 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
0 | $0 | 671,494 (Indirect) |
View |
| 2021-06-16 Ownership |
2022-02-10 4:47 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
80,000 | $0 | 1,388,654 (Direct) |
View |
Ownership |
2022-02-10 4:47 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
0 | $0 | 1,388,654 (Indirect) |
View |
| 2022-02-08 Exercise |
2022-02-10 08:32 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $13.85 | 128,857 (Direct) |
View |
| 2022-02-08 Exercise |
2022-02-10 08:32 am |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $0 | 128,857 (Direct) |
View |
| 2022-01-21 Option Award(A) |
2022-02-07 8:06 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
25,773 | $0 | 34,255 (Direct) |
View |
| 2022-01-21 Option Award(A) |
2022-02-07 8:06 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
33,648 | $0 | 44,020 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
434 | $38.59 | 28,582 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
434 | $38.59 | 20,530 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
434 | $38.59 | 32,989 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:07 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
650 | $38.59 | 103,941 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
650 | $38.59 | 35,555 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
650 | $38.59 | 104,278 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
650 | $38.59 | 142,935 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
800 | $38.59 | 44,908 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
931 | $38.59 | 894,707 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
2,024 | $38.59 | 1,572,874 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 5:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
434 | $38.59 | 23,474 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 5:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
642 | $38.59 | 53,857 (Direct) |
View |